Globus Medical (GMED) Income from Continuing Operations (2011 - 2026)
Globus Medical (GMED) posted Income from Continuing Operations of 124302000.0 for Q1 2026, down 11.59% on a QoQ basis from 140594000.0 in Q4 2025, and up 64.72% year-over-year from 75462000.0 in Q1 2025.
Globus Medical (GMED) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Globus Medical's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 124302000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 64.72% year-over-year to 124302000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 586708000.0 (up 216.18% YoY) and the FY2025 annual result came in at 537868000.0, up 422.28% from the prior year.
- Income from Continuing Operations was 124302000.0 for Q1 2026 at Globus Medical, down from 140594000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 202846000.0 in Q2 2025 and bottomed at 7159000.0 in Q1 2024.
- A 5-year average of 62107352.94 and a median of 49129000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Peak annual rise in Income from Continuing Operations reached 5093.99% in 2024, while the deepest fall reached 114.57% in 2024.
- Globus Medical's Income from Continuing Operations stood at 27735000.0 in 2022, then plunged by 45.79% to 15034000.0 in 2023, then surged by 76.3% to 26505000.0 in 2024, then surged by 430.44% to 140594000.0 in 2025, then declined by 11.59% to 124302000.0 in 2026.
- Business Quant data shows GMED's Income from Continuing Operations at 124302000.0 in Q1 2026, 140594000.0 in Q4 2025, and 118966000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 124.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.30 Mn |
| Dec 31, 2025 | 140.59 Mn |
| Sep 30, 2025 | 118.97 Mn |
| Jun 30, 2025 | 202.85 Mn |
| Mar 31, 2025 | 75.46 Mn |
| Dec 31, 2024 | 26.51 Mn |
| Sep 30, 2024 | 51.84 Mn |
| Jun 30, 2024 | 31.76 Mn |
| Mar 31, 2024 | -7.16 Mn |
| Dec 31, 2023 | 15.03 Mn |
| Sep 30, 2023 | 998,000.00 |
| Jun 30, 2023 | 57.71 Mn |
| Mar 31, 2023 | 49.13 Mn |
| Dec 31, 2022 | 27.74 Mn |
| Sep 30, 2022 | 47.43 Mn |
| Jun 30, 2022 | 54.59 Mn |
| Mar 31, 2022 | 38.08 Mn |
| Dec 31, 2021 | -169.71 Mn |
| Sep 30, 2021 | 47.21 Mn |
| Jun 30, 2021 | 41.55 Mn |